Randomized phase III study of granulocyte transfusions in neutropenic patients

Bone Marrow Transplantation

Volumn 42, Issue 10, 2008, Pages 679-684

  Seidel, M G ^a   Peters, C ^a   Wacker, A ^b   Northoff, H ^b   Moog, R ^c   Boehme, A ^d   Silling, G ^e   Grimminger, W ^f   Einsele, H ^g  

^a ST ANNA CHILDREN S HOSPITAL   (Austria)

^b Medizinische Klinik II   (Germany)

^c UNIVERSITY HOSPITAL ESSEN   (Germany)

^d Zentrum der Inneren Medizin   (Germany)

^e UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^f Klinikum Schwäbisch Gemünd   (Germany)

^g UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; ANTIPYRETIC AGENT; GRANULOCYTE COLONY STIMULATING FACTOR; PREDNISOLONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADOLESCENT; ADULT; AGED; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; BACTERIAL INFECTION; CLINICAL RESEARCH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; DRUG EFFICACY; DRUG MEGADOSE; DYSPNEA; FEBRILE NEUTROPENIA; FEMALE; GRAFT VERSUS HOST REACTION; GRANULOCYTE TRANSFUSION; HEMATOLOGIC DISEASE; HEMATOLOGIC MALIGNANCY; HUMAN; INCIDENCE; LEUKAPHERESIS; LUNG DISEASE; LUNG INFILTRATE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MYCOSIS; NAUSEA AND VOMITING; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RANDOMIZED CONTROLLED TRIAL; RASH; SOFT TISSUE DISEASE; SURVIVAL RATE;

ADOLESCENT; ADULT; AGED; FEMALE; GRANULOCYTES; HEMATOLOGIC DISEASES; HUMANS; INFECTION; LEUKOCYTE TRANSFUSION; MALE; MIDDLE AGED; NEOPLASMS; NEUTROPENIA; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 57049146865     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2008.237     Document Type: Article

References (27)

1. Bensinger WI, Price TH, Dale DC, Appelbaum FR, Clift R, Lilleby K et al. The effects of daily recombinant human granulocyte colony-stimulating factor administration on normal granulocyte donors undergoing leukapheresis. Blood 1993; 81: 1883-1888.
2. Dignani MC, Anaissie EJ, Hester JP, O'Brien S, Vartivarian SE, Rex JH et al. Treatment of neutropenia-related fungal infections with granulocyte colony-stimulating factor-elicited white blood cell transfusions: A pilot study. Leukemia 1997; 11: 1621-1630.
3. Kerr JP, Liakopolou E, Brown J, Cornish JM, Fleming D, Massey E et al. The use of stimulated granulocyte transfusions to prevent recurrence of past severe infections after allogeneic stem cell transplantation. Br J Haematol 2003; 123: 114-118.
4. Peters C, Minkov M, Matthes-Martin S, Potschger U, Witt V, Mann G et al. Leucocyte transfusions from rhG-CSF or prednisolone stimulated donors for treatment of severe infections in immunocompromised neutropenic patients. Br J Haematol 1999; 106: 689-696.
5. Schiffer CA. Granulocyte transfusion therapy 2006: The comeback kid? Med Mycol 2006; 44 (Suppl): 383-386.
6. Cairo MS, Worcester CC, Rucker RW, Hanten S, Amlie RN, Sender L et al. Randomized trial of granulocyte transfusions versus intravenous immune globulin therapy for neonatal neutropenia and sepsis. J Pediatr 1992; 120 (2 Part 1): 281-285.
7. Caspar CB, Seger RA, Burger J, Gmur J. Effective stimulation of donors for granulocyte transfusions with recombinant methionyl granulocyte colony-stimulating factor. Blood 1993; 81: 2866-2871.
8. Colotta F, Re F, Mantovani A. Granulocyte transfusions from granulocyte colony-stimulating factor-treated donors: Also a question of cell survival? Blood 1993; 82: 2258.
9. Illerhaus G, Wirth K, Dwenger A, Waller CF, Garbe A, Brass V et al. Treatment and prophylaxis of severe infections in neutropenic patients by granulocyte transfusions. Ann Hematol 2002; 81: 273-281.
10. Klein HG, Strauss RG, Schiffer CA. Granulocyte transfusion therapy. Semin Hematol 1996; 33: 359-368.
11. Lee JJ, Chung IJ, Park MR, Kook H, Hwang TJ, Ryang DW et al. Clinical efficacy of granulocyte transfusion therapy in patients with neutropenia-related infections. Leukemia 2001; 15: 203-207.
12. Mousset S, Hermann S, Klein SA, Bialleck H, Duchscherer M, Bomke B et al. Prophylactic and interventional granulocyte transfusions in patients with haematological malignancies and life-threatening infections during neutropenia. Ann Hematol 2005; 84: 734-741.
13. Rex JH, Bhalla SC, Cohen DM, Hester JP, Vartivarian SE, Anaissie EJ. Protection of human polymorphonuclear leukocyte function from the deleterious effects of isolation, irradiation, and storage by interferon-gamma and granulocyte-colony-stimulating factor. Transfusion 1995; 35: 605-611.
14. Sachs UJ, Reiter A, Walter T, Bein G, Woessmann W. Safety and efficacy of therapeutic early onset granulocyte transfusions in pediatric patients with neutropenia and severe infections. Transfusion 2006; 46: 1909-1914.
15. Safdar A, Hanna HA, Boktour M, Kontoyiannis DP, Hachem R, Lichtiger B et al. Impact of high-dose granulocyte transfusions in patients with cancer with candidemia: Retrospective case-control analysis of 491 episodes of Candida species bloodstream infections. Cancer 2004; 101: 2859-2865.
16. Price TH. Granulocyte transfusion: Current status. Semin Hematol 2007; 44: 15-23.
17. Stanworth SJ ME, Hyde C, Brunskill S, Lucas G, Navarrete C, Marks DI. Granulocyte transfusions for treating infections in patients with neutropenia or neutrophil dysfunction. Cochrane Database of Systematic Reviews 2005; 20 May 2005 (cited 4 may 2007); 3 [Available from: http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/ CD005339/frame.html.].
18. Anderlini P, Korbling M, Dale D, Gratwohl A, Schmitz N, Stroncek D et al. Allogeneic blood stem cell transplantation: Considerations for donors. Blood 1997; 90: 903-908.
19. Seidel MG, Minkov M, Witt V, Matthes-Martin S, Mann G, Pötschger U et al. Granulocyte transfusions in children and young adults - does the dose matter? 2008 (manuscript in preparation).
20. Roilides E, Holmes A, Blake C, Pizzo PA, Walsh TJ. Effects of granulocyte colony-stimulating factor and interferon-gamma on antifungal activity of human polymorphonuclear neutrophils against pseudohyphae of different medically important Candida species. J Leukoc Biol 1995; 57: 651-656.
21. Safdar A, Rodriguez G, Ohmagari N, Kontoyiannis DP, Rolston KV, Raad II et al. The safety of interferon-gamma-1b therapy for invasive fungal infections after hematopoietic stem cell transplantation. Cancer 2005; 103: 731-739.
22. Safdar A, Rodriguez GH, Lichtiger B, Dickey BF, Kontoyiannis DP, Freireich EJ et al. Recombinant interferon gamma1b immune enhancement in 20 patients with hematologic malignancies and systemic opportunistic infections treated with donor granulocyte transfusions. Cancer 2006; 106: 2664-2671.
23. Akpek G, Knight RD, Wright DG. Use of oral mucosal neutrophil counts to detect the onset and resolution of profound neutropenia following high-dose myelosuppressive chemotherapy. Am J Hematol 2003; 72 13-19.
24. Freedman B. Equipoise and the ethics of clinical research. New Engl J Med 1987; 317: 141-145.
25. Adkins DR, Goodnough LT, Shenoy S, Brown R, Moellering J, Khoury H et al. Effect of leukocyte compatibility on neutrophil increment after transfusion of granulocyte colony-stimulating factor-mobilized prophylactic granulocyte transfusions and on clinical outcomes after stem cell transplantation. Blood 2000; 95: 3605-3612.
26. Briones MA, Josephson CD, Hillyer CD. Granulocyte transfusion: revisited. Curr Hematol Rep 2003; 2: 522-527.
27. Grigull L, Pulver N, Goudeva L, Sykora KW, Linderkamp C, Beilken A et al. G-CSF mobilised granulocyte transfusions in 32 paediatric patients with neutropenic sepsis. Support Care Cancer 2006; 14 910-916.